As of January 22, 2025, Disc Medicine (IRON) has a market cap of $1.74 billion USD. According to our data, Disc Medicine is ranked No.4356 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.74 B |
-7.73%
|
Dec 31, 2024 | $1.89 B |
9.76%
|
Dec 29, 2023 | $1.72 B |
190.40%
|
Dec 30, 2022 | $0.59 B |
-77.22%
|
Dec 31, 2021 | $2.60 B |
-73.55%
|
Dec 31, 2020 | $9.82 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Agios Pharmaceuticals
AGIO
|
$1.94 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
-0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.11 B |
-0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
0.000 M
|
USA
|
BioCryst Pharmaceuticals
BCRX
|
$1.58 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Market Cap | = | IRON Stock Price | * | IRON Shares Outstanding |
= | $58.50 | * | 29.76 M | |
= | $1.74 B |